Week 3 Flashcards
1
Q
A
MOA
Steroids
2
Q
Clinical Uses of Prednisone, Prednisolone, Hydrocortisone, and Dexamethasone
A
CU
3
Q
Adverse Effects of Prednisone, Prednisolone, Hydrocortisone, and Dexamethasone
A
AE
4
Q
A
MOA
Steroids
5
Q
Clinical Uses of Fludrocortisone
A
CU
6
Q
Adverse Effects of Fludrocortisone
A
AE
7
Q
A
MOA
Azole Antifungal
8
Q
Clinical Uses of Ketoconazole
A
CU
9
Q
Adverse Effects of Ketoconazole
A
AE
10
Q
A
MOA
11
Q
Clinical Uses of Mitotane
A
CU
12
Q
Adverse Effects of Mitotane
A
AE
13
Q
A
MOA
14
Q
Clinical Uses of Metyrapone
A
CU
15
Q
Adverse Effects of Metyrapone
A
AE
16
Q
A
MOA
17
Q
Clincal Uses of Levothyroxine
A
CU
18
Q
Adverse Effects of Levothyroxine
A
AE
19
Q
A
MOA
Thioamide
20
Q
Clinical Uses of Propylthiouracil
A
CU
21
Q
Adverse Effects of Propylthiouracil
A
AE
22
Q
A
MOA
Thioamide
23
Q
Clinical Uses of Methimazole
A
CU
24
Q
Adverse Effects of Methimazole
A
AE
25
MOA
26
Clinical Uses of Potassium Iodide (SSKI/Lugol's Solution)
CU
27
Adverse Effects of Potassium Iodide (SSKI/Lugol's Solution)
AE
28
MOA
## Footnote
**Beta-Blocker**
29
Clinical Uses of Propanolol
CU
30
Adverse Effects of Propanolol
AE
31
MOA
## Footnote
**hGH analog**
32
Clinical Uses of Somatropin
CU
33
Adverse Effects of Somatropin
AE
34
MOA
## Footnote
**Somastatin agonist**
35
Clinical Uses of Octreotide, Lanreotide, and Pasireotide
CU
36
Adverse Effects of Octreotide, Lanreotide, and Pasireotide
AE
37
MOA
## Footnote
Growth Hormone Receptor Antagonist
38
Clinical Uses of Pegvisomant
CU
39
AE Pegvisomant
AE
